Nucleic Acid-Based Point-of-Care Testing Market: Recent...

agrega un archivo Other

2023-10-05 06:39:10 -

Nucleic Acid-Based Point-of-Care Testing Market: Recent Advancements and Growth Potential

The global Nucleic Acid Testing Market was valued at USD 4.23 Billion in 2022. It is projected to reach USD 7.57 Billion by 2032, with a compound annual growth rate (CAGR) of 6.7% during the forecast period. The market is primarily propelled by the increasing occurrence of infectious diseases and the need for accurate and rapid diagnostic tests. Nucleic Acid Testing (NAT), a technology...

0 Commentarios 0 Acciones 1486 Views 0 Vista previa